Claim Missing Document
Check
Articles

Found 14 Documents
Search

Public Knowledge, Trust, Attitude, and Behavioral Intention toward the Integration of Jamu into National Health Services Mohamad Kashuri; Taruna Ikrar
Borneo Journal of Pharmacy Vol. 9 No. 2 (2026): Borneo Journal of Pharmacy
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/bjop.v9i2.10019

Abstract

The integration of jamu into Indonesia's formal healthcare system remains an important policy issue, particularly in ensuring that regulatory development is matched by public acceptance and behavioral readiness. This study aimed to examine public perceptions of integrating jamu into national health services using a Theory of Planned Behavior (TPB)-informed framework. A quantitative cross-sectional survey was conducted among 300 webinar participants aged 18 years or older using purposive sampling. Data were collected through an anonymous online questionnaire comprising 12 items across four latent constructs: knowledge, trust, attitude, and behavioral intention. The relationships among constructs were analyzed using partial least squares structural equation modeling (PLS-SEM). The results showed that attitude was the strongest predictor of behavioral intention (β = 0.837, p <0.001), while knowledge significantly influenced trust (β = 0.651) and attitude (β = 0.248), and trust also significantly influenced attitude (β = 0.486). The model explained 70% of the variance in behavioral intention, indicating substantial explanatory power. These findings suggest a coherent behavioral pathway in which knowledge and trust strengthen attitude, which in turn drives public intention to support the integration of jamu into formal healthcare services. The study concludes that successful integration depends not only on regulatory readiness but also on strengthening public knowledge, trust, and attitudes toward traditional medicine. However, the findings should be interpreted cautiously because the sample was non-random and relatively digitally literate. Future studies should include more diverse populations and use longitudinal or mixed-method approaches to support evidence-based integration policies.
Analysis of Trends in Cosmetics Supervision Cases in Indonesia in 2021-2024 Mohamad Kashuri; Taruna Ikrar; Gunawan Indrayanto
Eruditio : Indonesia Journal of Food and Drug Safety Vol 5 No 2 (2025): Edisi Juni
Publisher : Badan Pengawas Obat dan Makanan

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54384/eruditio.v5i2.235

Abstract

This study offers a comprehensive analysis of cosmetic product regulation in Indonesia from 2021 to 2024, examining enforcement trends, patterns of regulatory non-compliance, and the evolving oversight role of the Indonesian Food and Drug Authority (BPOM). Data were obtained from BPOM’s annual inspection and enforcement reports and analyzed descriptively to identify changes in regulatory compliance over time. The results reveal that the majority of violations originated from Small and Medium-Sized Enterprises (SMEs), accounting for 1–2% of total cases, while larger industries reported slightly higher rates (2.7–6.9%). A significant 165% surge in products without distribution permits was recorded from 2021 to 2022, followed by substantial reductions in 2023 (85%) and 2024 (32%). Adherence to Good Cosmetic Manufacturing Practices (GCMP) showed a consistent improvement from 2022 onwards. Violations involving labeling, advertising, and product claims also declined, though more than 1,500 cases are still reported annually. Public education campaigns have played a crucial role in enhancing consumer awareness and minimizing exposure to unsafe products. Enforcement data further demonstrate a reduction in formal sanctions and warnings, reflecting BPOM’s strategic pivot toward a more preventive and facilitative regulatory approach. Looking ahead, BPOM needs to strengthen industry compliance by expanding its technical assistance initiatives through both direct consultations and digital platforms, supporting a more risk-based and innovation-friendly regulatory environment.
The Biotechnological Potential of Tissue Culture for the Conservation and Production of Secondary Metabolites in Pimpinella pruatjan (Purwoceng): A Systematic Literature Review Mohamad Kashuri
Green Health International Journal of Health Sciences Nursing and Nutrition Vol. 2 No. 3 (2025): July : Green Health: International Journal of Health Sciences, Nursing and Nutr
Publisher : International Forum of Researchers and Lecturers

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.70062/greenhealth.v2i3.157

Abstract

Pimpinella pruatjan is a native Indonesian medicinal plant increasingly threatened by overexploitation and limited cultivation techniques. This study aims to systematically review the role of tissue culture in the conservation and production of its secondary metabolites. Using the Systematic Literature Review (SLR) method, data were gathered from scientific literature published in the last five years through open-access databases. The findings reveal that tissue culture techniques not only effectively regenerate purwoceng but also significantly enhance the production of bioactive compounds such as flavonoids, betaine, and sterols. This study demonstrates that biotechnology-based tissue culture is a strategic solution for conserving endangered medicinal plants while optimizing their utilization for biodiversity-based pharmaceutical industries.
Regulatory challenges and policy strategies for stem cell-based cosmetics in Indonesia Kashuri, Mohamad
Borobudur Pharmacy Review Vol. 5 No. 2 (2025): August-Dec
Publisher : Universitas Muhammadiyah Magelang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31603/bphr.v5i2.13701

Abstract

Introduction: Stem cell-based cosmetics are gaining popularity in Indonesia due to their regenerative and anti-aging properties. However, these products are still governed under a general cosmetic notification system that lacks specific provisions for efficacy validation, safety evaluation, and ethical oversight. The absence of clear regulations may pose significant risks to consumer safety and undermine the credibility of cosmetic biotechnology innovations. Therefore, this study aims to critically analyze the current regulatory landscape surrounding stem cell-based cosmetics in Indonesia, identify key policy gaps, and propose strategic recommendations for establishing a more robust, ethical, and science-based regulatory framework Method: This study employed a narrative literature review approach, analyzing 28 peer-reviewed and open-access publications published between 2020 and 2025. The sources include scientific journals, national regulatory documents, and institutional policy papers that discuss the application of stem cells in cosmetics and their governance within public health frameworks. Results: The review reveals that Indonesia does not yet have a distinct regulatory classification for biotechnology-based cosmetic products. There is no requirement for pre-market efficacy testing or for the disclosure of stem cell origin and processing. In contrast, countries such as South Korea and the European Union have implemented comprehensive regulatory frameworks that ensure transparency, product safety, and ethical compliance. Discussion: The findings indicate that Indonesia’s current passive regulatory approach may compromise consumer protection and fail to respond effectively to emerging biotechnological trends. To close these regulatory gaps, the study proposes the establishment of a specific category for stem cell-based cosmetics, the enforcement of mandatory safety and efficacy evaluations, and the creation of a scientific advisory board to align national regulations with international standards and best practices.